You have successfully logged out.
Company News
Newsroom
Stay up-to-date with our latest company news.
July 14, 2026
B. Braun Announces Approval and Commercialization of First Generic Sugammadex Injection in the U.S. Market
We announced the FDA approval and commercialization of the first generic Sugammadex Injection in the U.S. market: Sugammadex Injection, 200 mg/2 mL (100 mg/mL), an AP-rated generic BRIDION®1* (Sugammadex Injection). Supplied in a single-dose vial with a 24-month shelf life, the product will be available July 28, 2026. Sugammadex is indicated for the reversal of neuromuscular blockade induced by rocuronium bromide.
Read more
May 4, 2026
B. Braun Launches Rocuronium Bromide Injection in a Room-Temperature-Stable Prefilled Syringe
We launched the Rocuronium Bromide Injection, the first and only FDA-approved,** room-temperature-stable prefilled syringe—supplied as a 50 mg/5 mL (10 mg/mL) single-dose Luer lock syringe. The preservative-free formulation is provided in a sterile solution.
Read moreMarch 5, 2026
B. Braun Announces Significant Reduction of Greenhouse Gas Emissions through Renewable Electricity Purchase Agreements
We announced we are switching to 100% renewable electricity for all U.S. operations starting in 2026, cutting our Scope 1 & 2 CO₂e emissions in North America by 30% and representing a significant investment in renewable energy deployment. This move supports our goal to reducing CO₂e emissions 50% by 2030*** and includes investments like a new fuel cell microgrid at our Irvine, CA manufacturing facility.
Read more
Press release archive
B. Braun Announces Approval and Commercialization of First Generic Sugammadex Injection in the U.S. Market
July 14, 2026
B. Braun Launches Rocuronium Bromide Injection in a Room-Temperature-Stable Prefilled Syringe
May 4, 2026
B. Braun Announces Significant Reduction of Greenhouse Gas Emissions through Renewable Electricity Purchase Agreements
March 5, 2026
B. Braun Announces Retirement of Chief Executive Officer Rob Albert
February 2, 2026
Lehigh County Court denies class action in ethylene oxide case
January 13, 2026
B. Braun Launches First-of-its-Kind Supply Assurance Program to Strengthen Supply Chain Resiliency and Support Uninterrupted Patient Care
December 15, 2025
B. Braun Launches Midazolam in 0.8% Sodium Chloride Injection with Enhanced Safety and Usability Features
October 15, 2025
B. Braun Receives Nurse Approved Certification for Full IV Solutions Portfolio Not Made with DEHP or PVC, Plastic Irrigation Containers and Pip-Taz in DUPLEX®
September 24, 2025
B. Braun Launches Tromethamine Injection in EXCEL® IV Container
September 15, 2025
B. Braun SE Acquires True Digital Surgery
September 12, 2025
B. Braun Expands Heparin Sodium Injection Portfolio to Seven Heparin Premixed Sodium Injection Products
July 18, 2025
B. Braun Launches EZCOVER® Probe Cover Set for Improved Ultrasound Safety in Peripheral Nerve Block Procedures
April 14, 2025
B. Braun Launches Ready-to-Activate Cefazolin 3 Gram Pre-Mix in DUPLEX® Containers
March 24, 2025
B. Braun Launches First Ever Emergency Department-Specific Nerve Block Tray
February 18, 2025
B. Braun Launches Clik-FIX® Epidural/PNB Catheter Securement Device
January 21, 2025
B. Braun Takes Steps to Secure the Supply of Critical IV Fluids in the US
October 18, 2024
B. Braun Medical Receives FDA Clearance for Introcan Safety® 2 Deep Access IV Catheter
September 24, 2024
B. Braun Medical Announces First U.S. Conversion to NRFit® Connectors
July 24, 2024
B. Braun Launches Levetiracetam in Sodium Chloride Injection Portfolio
May 28, 2024
B. Braun and Orlando Health to Collaborate on Healthcare Innovation
March 5, 2024
B. Braun of America Appoints Two Executive Leadership Team Members to its Board of Directors
March 1, 2024
B. Braun Launches Heparin Sodium 2,000 Units in 0.9% Sodium Chloride Injection, 1,000 mL (2 units/mL)
February 13, 2024
Rob Albert appointed Chief Executive Officer of B. Braun of America Inc.
January 24, 2024
B. Braun Launches the CARESITE Micro™ Luer Access Device and Extension Sets
December 14, 2023
B. Braun of America Appoints Two Global Healthcare Leaders to its Board of Directors
October 27, 2023
B. Braun Announces Comprehensive Resources to Address Health Inequities in Vascular Access and Care
October 13, 2023
Braun Launches Introcan Safety® 2 IV Catheter with Multi-Access Blood Control
October 11, 2023
B. Braun Receives FDA Clearance for AQUAbase® nX Reverse Osmosis System
September 18, 2023
B. Braun Launches DoseTrac® Enterprise Infusion Management Software
June 1, 2023
B. Braun Launches Online e-University Platform for Healthcare Providers
March 7, 2023
B. Braun’s Space® Infusion Pump Systems Earn UL 2900-2-1 Certification
December 1, 2022
B. Braun and Lehigh Valley Health Network to Collaborate on Recycling Medical Plastics Waste
October 18, 2022
AVA, B. Braun Partnership Continues to Raise Standards for PIV Education and Training with Launch of New Certificate Course on Vascular Access
September 29, 2022
B. Braun Acquires Clik-FIX® Catheter Securement Devices from Starboard Medical
September 27, 2022
B. Braun Launches Introcan Safety® 2 IV Catheter with One-time Blood Control Designed to Make IV Access Safer for Clinicians
July 12, 2022
B. Braun and Massachusetts General Hospital to Collaborate on Healthcare Delivery Challenges
May 10, 2022
AVA, B. Braun Launch Second Fundamentals of Peripheral Intravenous Vascular Access Course
February 22, 2022
B. Braun Receives FDA Approval of Daytona Beach Pharmaceutical Manufacturing Site
January 28, 2022
B. Braun Announces Nationwide Availability of Magnesium Sulfate Family of Products
December 8, 2021
B. Braun Medical Launches Next Generation OnGuard® 2 CSTD
December 2, 2021
B. Braun Launches CARESAFE™ IV Administration Sets With Optional AirStop
September 21, 2021
B. Braun Announces Jennifer Prioleau as New Chief Legal Officer and Chief Compliance Officer
June 30, 2021
B. Braun Receives the First and Only FDA Approval for Acetaminophen Injection in Multiple Doses
February 25, 2021
B. Braun Announces James Allen as New Chief Financial Officer
February 23, 2021
Information on Unauthorized Distribution of Introcan Safety® Catheters
February 3, 2021
B. Braun Infusomat® Space® Infusion Pump Receives 2021 Best in KLAS Award for Traditional Smart Pumps
February 2, 2021
Company statements
Media Relations
If you are a journalist and have questions about B. Braun or need any material which you cannot find in our newsroom, you are welcome to get in contact with us.
Allison Longenhagen
Director, Corporate Communications
References
1. U.S. Food and Drug Administration. Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book). Sugammadex sodium listing. Accessed May 20, 2026.
*BRIDION® is a registered trademark of Merck Sharp & Dohme LLC.
**Data on file.
***This move supports our goal to reducing CO₂e emissions 50% by 2030* and includes investments like a new fuel cell microgrid at our Irvine, CA manufacturing facility.